| Curect Neuropsychology Of New Jersey, Llc | |
|
55 Madison Ave Ste 400 Morristown NJ 07960-7397 | |
| (973) 983-3443 | |
| (516) 246-5595 |
| Full Name | Curect Neuropsychology Of New Jersey, Llc |
|---|---|
| Speciality | Psychologist |
| Location | 55 Madison Ave Ste 400, Morristown, New Jersey |
| Authorized Official Name and Position | Elina Kugel (OWNER) |
| Authorized Official Contact | 7187907727 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Curect Neuropsychology Of New Jersey, Llc 55 Madison Ave Ste 400 Morristown NJ 07960-7397 Ph: (973) 983-3443 | Curect Neuropsychology Of New Jersey, Llc 55 Madison Ave Ste 400 Morristown NJ 07960-7397 Ph: (973) 983-3443 |
| NPI Number | 1154032985 |
|---|---|
| Provider Enumeration Date | 12/13/2022 |
| Last Update Date | 05/31/2023 |
| Certification Date | 05/31/2023 |
| Medicare PECOS PAC ID | 5294109450 |
|---|---|
| Medicare Enrollment ID | O20230518000103 |
News Archive
Bedford Laboratories™, a division of Ben Venue Laboratories, Inc., a provider of select specialty injectables, is pleased to announce the addition of Indomethacin for Injection to its existing product line. This product is AP rated and is equivalent to Indocin® by Lundbeck, Inc. Indomethacin for Injection is indicated to close a hemodynamically significant patent ductus arteriosus in premature infants weighing between 500 and 1750 g when after 48 hours usual medical management (e.g., fluid restriction, diuretics, digitalis, respiratory support, etc.) is ineffective.
Arrowhead Research Corporation, today announced that it has acquired RNA therapeutics assets from Roche including the state-of-the-art research site in Madison, WI.
Glioblastoma is a guileful enemy. While most of the brain tumor can often be removed surgically, in virtually every case the tumor reappears. One reason for this is that sporadic, infiltrative tumor cells will remain in the brain even after most careful surgery. Researchers at the University of Bonn have now subjected these 'forgotten' cells to closer scrutiny for the first time.
Promethera Biosciences, a Belgian biotechnology company developing Promethera HepaStem, a cell-based therapy for the treatment of in-born errors of metabolism and acquired liver diseases, today announces the completion of its Series C fundraising round. The company has raised €25.33 million ($31.4 million), including €20.33 million in capital.
› Verified 7 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1154032985 | NPI | - | NPPES |
| Provider Name | Yelena Goldin |
|---|---|
| Provider Type | Practitioner - Clinical Psychologist |
| Provider Identifiers | NPI Number: 1063765808 PECOS PAC ID: 4486894698 Enrollment ID: I20130711000831 |
News Archive
Bedford Laboratories™, a division of Ben Venue Laboratories, Inc., a provider of select specialty injectables, is pleased to announce the addition of Indomethacin for Injection to its existing product line. This product is AP rated and is equivalent to Indocin® by Lundbeck, Inc. Indomethacin for Injection is indicated to close a hemodynamically significant patent ductus arteriosus in premature infants weighing between 500 and 1750 g when after 48 hours usual medical management (e.g., fluid restriction, diuretics, digitalis, respiratory support, etc.) is ineffective.
Arrowhead Research Corporation, today announced that it has acquired RNA therapeutics assets from Roche including the state-of-the-art research site in Madison, WI.
Glioblastoma is a guileful enemy. While most of the brain tumor can often be removed surgically, in virtually every case the tumor reappears. One reason for this is that sporadic, infiltrative tumor cells will remain in the brain even after most careful surgery. Researchers at the University of Bonn have now subjected these 'forgotten' cells to closer scrutiny for the first time.
Promethera Biosciences, a Belgian biotechnology company developing Promethera HepaStem, a cell-based therapy for the treatment of in-born errors of metabolism and acquired liver diseases, today announces the completion of its Series C fundraising round. The company has raised €25.33 million ($31.4 million), including €20.33 million in capital.
› Verified 7 days ago
| Provider Name | Elina Kugel |
|---|---|
| Provider Type | Practitioner - Clinical Psychologist |
| Provider Identifiers | NPI Number: 1699149229 PECOS PAC ID: 1355680307 Enrollment ID: I20230612000382 |
News Archive
Bedford Laboratories™, a division of Ben Venue Laboratories, Inc., a provider of select specialty injectables, is pleased to announce the addition of Indomethacin for Injection to its existing product line. This product is AP rated and is equivalent to Indocin® by Lundbeck, Inc. Indomethacin for Injection is indicated to close a hemodynamically significant patent ductus arteriosus in premature infants weighing between 500 and 1750 g when after 48 hours usual medical management (e.g., fluid restriction, diuretics, digitalis, respiratory support, etc.) is ineffective.
Arrowhead Research Corporation, today announced that it has acquired RNA therapeutics assets from Roche including the state-of-the-art research site in Madison, WI.
Glioblastoma is a guileful enemy. While most of the brain tumor can often be removed surgically, in virtually every case the tumor reappears. One reason for this is that sporadic, infiltrative tumor cells will remain in the brain even after most careful surgery. Researchers at the University of Bonn have now subjected these 'forgotten' cells to closer scrutiny for the first time.
Promethera Biosciences, a Belgian biotechnology company developing Promethera HepaStem, a cell-based therapy for the treatment of in-born errors of metabolism and acquired liver diseases, today announces the completion of its Series C fundraising round. The company has raised €25.33 million ($31.4 million), including €20.33 million in capital.
› Verified 7 days ago
| Provider Name | Adam Barkey |
|---|---|
| Provider Type | Practitioner - Clinical Psychologist |
| Provider Identifiers | NPI Number: 1801220561 PECOS PAC ID: 0042559924 Enrollment ID: I20230627000226 |
News Archive
Bedford Laboratories™, a division of Ben Venue Laboratories, Inc., a provider of select specialty injectables, is pleased to announce the addition of Indomethacin for Injection to its existing product line. This product is AP rated and is equivalent to Indocin® by Lundbeck, Inc. Indomethacin for Injection is indicated to close a hemodynamically significant patent ductus arteriosus in premature infants weighing between 500 and 1750 g when after 48 hours usual medical management (e.g., fluid restriction, diuretics, digitalis, respiratory support, etc.) is ineffective.
Arrowhead Research Corporation, today announced that it has acquired RNA therapeutics assets from Roche including the state-of-the-art research site in Madison, WI.
Glioblastoma is a guileful enemy. While most of the brain tumor can often be removed surgically, in virtually every case the tumor reappears. One reason for this is that sporadic, infiltrative tumor cells will remain in the brain even after most careful surgery. Researchers at the University of Bonn have now subjected these 'forgotten' cells to closer scrutiny for the first time.
Promethera Biosciences, a Belgian biotechnology company developing Promethera HepaStem, a cell-based therapy for the treatment of in-born errors of metabolism and acquired liver diseases, today announces the completion of its Series C fundraising round. The company has raised €25.33 million ($31.4 million), including €20.33 million in capital.
› Verified 7 days ago
News Archive
Bedford Laboratories™, a division of Ben Venue Laboratories, Inc., a provider of select specialty injectables, is pleased to announce the addition of Indomethacin for Injection to its existing product line. This product is AP rated and is equivalent to Indocin® by Lundbeck, Inc. Indomethacin for Injection is indicated to close a hemodynamically significant patent ductus arteriosus in premature infants weighing between 500 and 1750 g when after 48 hours usual medical management (e.g., fluid restriction, diuretics, digitalis, respiratory support, etc.) is ineffective.
Arrowhead Research Corporation, today announced that it has acquired RNA therapeutics assets from Roche including the state-of-the-art research site in Madison, WI.
Glioblastoma is a guileful enemy. While most of the brain tumor can often be removed surgically, in virtually every case the tumor reappears. One reason for this is that sporadic, infiltrative tumor cells will remain in the brain even after most careful surgery. Researchers at the University of Bonn have now subjected these 'forgotten' cells to closer scrutiny for the first time.
Promethera Biosciences, a Belgian biotechnology company developing Promethera HepaStem, a cell-based therapy for the treatment of in-born errors of metabolism and acquired liver diseases, today announces the completion of its Series C fundraising round. The company has raised €25.33 million ($31.4 million), including €20.33 million in capital.
› Verified 7 days ago
Sheila E Dancz Phd Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 43 Maple Ave, Morristown, NJ 07960 Phone: 973-993-9018 | |
Mrs. Wilson's Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 56 Mount Kemble Ave, Morristown, NJ 07960 Phone: 973-539-9626 | |
Janine M Tremblay Phd Apnc Mental Health Clinic Medicare: Medicare Enrolled Practice Location: 150 Madison Ave, Morristown, NJ 07960 Phone: 973-993-0945 | |
The Stocknoff Center Forgrowth And Development, Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 20 Elm St, Morristown, NJ 07960 Phone: 973-868-6204 | |
Brillon Counseling Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 77 Wildflower Ln, Morristown, NJ 07960 Phone: 862-215-0325 | |
Advanced Learning & Ddb Productions Mental Health Clinic Medicare: Medicare Enrolled Practice Location: 152 Speedwell Ave, Morristown, NJ 07960 Phone: 973-400-9794 Fax: 973-695-1465 | |
Rma Of New Jersey Complimentary Care Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 111 Madison Ave, Suite 100, Morristown, NJ 07960 Phone: 973-971-4600 |